06 February 2025
06 February 2025
The FDA rejected three prior regulatory applications before granting approval to the pharmaceutical company.
The MHRA said that the approval is part of the UK’s broader efforts towards global pandemic preparedness.
While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth.
Experts at the 2025 Clinical Trial Supply Europe will explore supply chain challenges and the impact of AI on trials.
The application is supported by outcomes from the GATHER1 and GATHER2 studies.
X-ELIO will supply clean energy to four companies through its Lorca Solar project.
The patent is set to remain in effect until at least 2034.
The initiative will focus on the production of nucleic acid-based vaccines and therapeutics.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
